Creative Medical Technology Ownership | Who Owns Creative Medical Technology?
Creative Medical Technology Ownership Summary
Creative Medical Technology is owned by 0.23% institutional investors, and 99.77% retail investors. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 0.70% of its assets in Creative Medical Technology shares.
CELZ Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Creative Medical Technology | 0.23% | - | 99.77% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2021 | 1 | - | 60,525 | - | - | - | 1 | - | - | - |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Institutional Extnd Mkt Idx Tr | 17.63K | 0.70% | - |
Fidelity Extended Market Index | 6.88K | 0.27% | -44.00 |
Fidelity Series Total Market Index | 2.13K | 0.08% | 693.00 |
Fidelity Total Market Index | 1.55K | 0.06% | - |
Northern Trust Extended Eq Market Idx | 705.00 | 0.04% | - |
NT Ext Equity Mkt Idx Fd - NL | 1.00K | 0.04% | - |
NT Ext Equity Mkt Idx Fd - DC - NL - T2 | 780.00 | 0.03% | -14.00 |
NT Ext Equity Mkt Idx Fd - L | 705.00 | 0.03% | - |
SSgA U.S. Extended Market Index Class I | 250.00 | 0.02% | - |
State St US Extended Mkt Indx NL Cl C | 250.00 | 0.01% | - |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 2 |
2023 Q2 | 4 | - |
2022 Q4 | 4 | - |
2022 Q3 | 7 | - |
2022 Q2 | 3 | - |
CELZ Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools